News Releases

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 8, 2024

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 6, 2024

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

October 31, 2024

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 28, 2024

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

October 15, 2024

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

October 7, 2024

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

September 30, 2024

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

September 24, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

September 18, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

September 3, 2024

« Previous
1
2
3
4
5
6
7
8
9
10
...31
Next »

Latest News & Events

Dec 15, 2025

Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic

Read More...

Dec 11, 2025

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants

Read More...

Dec 10, 2025

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025

Read More...